Mark S. Sands
Affiliations: | Washington University, Saint Louis, St. Louis, MO |
Area:
Molecular geneticsWebsite:
http://dbbs.wustl.edu/DBBS/website.nsf/RIB/5EE729EE796AEAE086256D4E005B2DAFGoogle:
"Mark Sands"Mean distance: 12883.8 (cluster 6)
Cross-listing: Chemistry Tree
Children
Sign in to add traineeAdarsh Reddy | grad student | 2004- | Washington University |
Megan A. Griffey | grad student | 2004 | Washington University |
August A. Hofling | grad student | 2005 | Washington University |
Anthony Donsante | grad student | 2006 | Washington University |
Josh C. Woloszynek | grad student | 2007 | Washington University |
Shannon L. Macauley-Rambach | grad student | 2009 | Washington University |
Jacqueline A. Hawkins | grad student | 2012 | Washington University |
Charles Shyng | grad student | 2010-2016 | Washington University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Takahashi K, Eultgen EM, Wang SH, et al. (2023) Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse model. The Journal of Clinical Investigation |
Nelvagal HR, Eaton SL, Wang SH, et al. (2022) Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep. The Journal of Clinical Investigation |
Babcock MC, Mikulka CR, Wang B, et al. (2021) Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor. Scientific Reports. 11: 14486 |
Bradbury AM, Bongarzone ER, Sands MS. (2021) Krabbe Disease: New Hope for an Old Disease. Neuroscience Letters. 135841 |
Heller GJ, Marshall MS, Issa Y, et al. (2021) Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Li Y, Miller CA, Shea LK, et al. (2020) Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Nelvagal HR, Hurtado ML, Eaton SL, et al. (2020) Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease. Scientific Reports. 10: 15157 |
Nelvagal HR, Dearborn JT, Ostergaard JR, et al. (2020) Spinal manifestations of CLN1 disease start during the early postnatal period. Neuropathology and Applied Neurobiology |
Bradbury AM, Bagel JH, Nguyen D, et al. (2020) Krabbe disease successfully treated via monotherapy of intrathecal gene therapy. The Journal of Clinical Investigation |
Mikulka CR, Dearborn JT, Benitez BA, et al. (2020) Cell-autonomous expression of the acid hydrolase galactocerebrosidase. Proceedings of the National Academy of Sciences of the United States of America |